Chekkera Shammi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chekkera Shammi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Clinical Psychiatry|September 28, 2010

"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trialGary Remington, Philip Seeman, Alan Feingold, et al.

The American Journal of Psychiatry|March 4, 2006

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidoneGary Remington, David Mamo, Alain Labelle, et al.

The Journal of Clinical Psychiatry|July 23, 2008

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophreniaHiroyuki Uchida, David C Mamo, Shitij Kapur, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Clinical Psychiatry|September 28, 2010

"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trialGary Remington, Philip Seeman, Alan Feingold, et al.

The American Journal of Psychiatry|March 4, 2006

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidoneGary Remington, David Mamo, Alain Labelle, et al.

The Journal of Clinical Psychiatry|July 23, 2008

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophreniaHiroyuki Uchida, David C Mamo, Shitij Kapur, et al.

Pageof 2